Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemostatic abnormalities in inflammatory bowel disease

E Chiarantini1, R Valanzano, A A Liotta

  • 1Istituto di Clinica Medica Generale e Cardiologia, Unita di Chirurgia Generale, University of Florence, Italy.

Thrombosis Research
|April 15, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nullius in Verba.

Updates in surgery·2022
Same author

Crtap and p3h1 knock out zebrafish support defective collagen chaperoning as the cause of their osteogenesis imperfecta phenotype.

Matrix biology : journal of the International Society for Matrix Biology·2020
Same author

Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects.

Clinical and experimental immunology·2018
Same author

Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion.

Journal of thrombosis and haemostasis : JTH·2016
Same author

OC-15 - Risk factors for cancer development after idiopathic venous thromboembolism.

Thrombosis research·2016
Same author

Zebrafish Collagen Type I: Molecular and Biochemical Characterization of the Major Structural Protein in Bone and Skin.

Scientific reports·2016

Inflammatory bowel disease (IBD) patients show increased blood clotting factors and platelet activity, contributing to a thrombophilic state. Antiphospholipid antibodies are more common but not the primary cause of clotting in IBD.

Area of Science:

  • Hematology
  • Gastroenterology
  • Immunology

Background:

  • Inflammatory bowel disease (IBD) is associated with a higher risk of thromboembolic events.
  • Understanding the hemostatic system's role in IBD is crucial for managing patient risk.

Purpose of the Study:

  • To investigate the hemostatic system and antiphospholipid antibody (aPL) presence in IBD patients.
  • To compare IBD patients with healthy controls regarding coagulation parameters.

Main Methods:

  • Evaluated platelet count (PLT), PT, aPTT, fibrinogen (Fib), prothrombin fragment F1+2, AT, PC, PS, FXIII, PLG, PA1, and platelet aggregation (PRP-SPA, WB-SPA).
  • Assessed antiphospholipid antibodies (aPL) in 41 Crohn's disease (CD) and 19 ulcerative colitis (UC) patients versus 40 controls.

Related Experiment Videos

Main Results:

  • IBD patients exhibited significantly increased PLT, Fib, F1+2, and WB-SPA in both active and inactive disease states.
  • Higher frequency of aPL positivity and significantly decreased FXIII were observed in IBD patients compared to controls.
  • The thrombophilic state in IBD was independent of disease activity or prior thrombotic events.

Conclusions:

  • IBD patients possess a distinct thrombophilic state characterized by altered coagulation parameters.
  • While aPL are more prevalent, they appear to reflect immunological changes rather than being the primary drivers of thrombosis in IBD.
  • The findings highlight the complex hemostatic alterations in IBD, necessitating further investigation into preventative strategies.